| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
N-[1-[(1S)-3-(dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide manufacturers
- GNE-9822
-
- $1960.00
-
2026-05-18
- CAS:1557232-32-2
- Purity: 99.90%
- Supply Ability: 10g
|
| | N-[1-[(1S)-3-(dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide Basic information |
| Product Name: | N-[1-[(1S)-3-(dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide | | Synonyms: | N-[1-[(1S)-3-(dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide;1H-Indazole-3-carboxamide, N-[1-[(1S)-3-(dimethylamino)-1-phenylpropyl]-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-6,6-dimethyl-;N-{1-[(1S)-3-(dimethylamino)-1-phenylpropyl]-1H-pyrazol-4-yl}-6,6-dimethyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide;GNE-9822 | | CAS: | 1557232-32-2 | | MF: | C24H32N6O | | MW: | 420.55 | | EINECS: | | | Product Categories: | | | Mol File: | 1557232-32-2.mol | ![N-[1-[(1S)-3-(dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide Structure](CAS/20180601/GIF/1557232-32-2.gif) |
| | N-[1-[(1S)-3-(dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide Chemical Properties |
| form | Solid | | color | Off-white to light yellow |
| | N-[1-[(1S)-3-(dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide Usage And Synthesis |
| Description | GNE-9822 is a potent and selective ITK inhibitor. GNE-9822 shows good ADME properties in preclinical species. Interleukin-2 inducible T-cell kinase (ITK), a member of the Tec family of tyrosine kinases, plays a major role in T-cell signaling downstream of the T-cell receptor (TCR), and considerable efforts have been directed toward discovery of ITK-selective inhibitors as potential treatments of inflammatory disorders such as asthma. | | Uses | GNE-9822 is a potent, orally active and selective ITK inhibitor with a Ki value of 0.7 nM, and an EC50 value of 354.5 nM. GNE-9822 has good ADME properties. GNE-9822 can be used in research of asthma[1][2]. | | in vivo | GNE-9822 (compound 28; po and iv; 1 and 5 mg/kg) has good bioavailability and halflives observed in mouse and rats[1]. | Animal Model: | BALB/c mouse and Sprague-Dawley rats[1] | | Dosage: | 1 and 5 mg/kg | | Administration: | po (5 mg/kg) and iv (1 mg/kg) | | Result: | 1.19| species | route | dose volume (mL/kg) | dose (mg/kg) | Cmax (μM) | AUC (μM·h) | Cl (mL/min/kg) | T1/2 (h) | Vss (L/kg) | %F | | mouse (BALB/c) | IV | 1.0 | 1.0 | | 1.5 | 40 | 2.9 | 10 | | | mouse (BALB/c) | PO | 5.0 | 50 | 3.8 | 2.7 | | | | 36 |
|
| Animal Model: | BALB/c mouse and Sprague-Dawley rats[1] | | Dosage: | 1 and 5 mg/kg | | Administration: | po (5 mg/kg) and iv (1 mg/kg) | | Result: | 1.19| species | route | dose volume (mL/kg) | dose (mg/kg) | Cmax (μM) | AUC (μM·h) | Cl (mL/min/kg) | T1/2 (h) | Vss (L/kg) | %F | | rat (Sprague-Dawley | IV | 1.0 | 1.0 | | 0.6 | 70 | 3.0 | 14 | | | rat (Sprague-Dawley | PO | 2.0 | 5.0 | 0.2 | 1.1 | | | | 40 |
|
| | References | [1] Zhou D, et al. Discovery of Potent and Highly Selective Interleukin-2-Inducible T-Cell Kinase Degraders with In Vivo Activity. J Med Chem. 2023 Apr 13;66(7):4979-4998. DOI:10.1021/acs.jmedchem.2c02078 [2] Burch JD, et, al. Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors. J Med Chem. 2014 Jul 10;57(13):5714-27. DOI:10.1021/jm500550e |
| | N-[1-[(1S)-3-(dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide Preparation Products And Raw materials |
|